Neuronetics Liabilities And Stockholders Equity from 2010 to 2024

STIM Stock  USD 1.92  0.02  1.05%   
Neuronetics Liabilities And Stockholders Equity yearly trend continues to be very stable with very little volatility. Liabilities And Stockholders Equity is likely to drop to about 100.9 M. Liabilities And Stockholders Equity is the total of all liabilities and equity in the company, which should equal Neuronetics' total assets according to the accounting equation. View All Fundamentals
 
Liabilities And Stockholders Equity  
First Reported
2017-12-31
Previous Quarter
115.8 M
Current Value
103.8 M
Quarterly Volatility
32.7 M
 
Covid
Check Neuronetics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Neuronetics main balance sheet or income statement drivers, such as Interest Income of 3.3 M, Depreciation And Amortization of 1.8 M or Interest Expense of 4.2 M, as well as many exotic indicators such as Price To Sales Ratio of 1.49, Dividend Yield of 0.0 or PTB Ratio of 1.94. Neuronetics financial statements analysis is a perfect complement when working with Neuronetics Valuation or Volatility modules.
  
This module can also supplement Neuronetics' financial leverage analysis and stock options assessment as well as various Neuronetics Technical models . Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.

Latest Neuronetics' Liabilities And Stockholders Equity Growth Pattern

Below is the plot of the Liabilities And Stockholders Equity of Neuronetics over the last few years. It is the total of all liabilities and equity in the company, which should equal the company's total assets according to the accounting equation. Neuronetics' Liabilities And Stockholders Equity historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Neuronetics' overall financial position and show how it may be relating to other accounts over time.
Liabilities And Stockholders Equity10 Years Trend
Slightly volatile
   Liabilities And Stockholders Equity   
       Timeline  

Neuronetics Liabilities And Stockholders Equity Regression Statistics

Arithmetic Mean65,544,543
Geometric Mean50,903,578
Coefficient Of Variation68.82
Mean Deviation41,577,645
Median38,938,000
Standard Deviation45,110,451
Sample Variance2035T
Range116.4M
R-Value0.85
Mean Square Error596.8T
R-Squared0.73
Significance0.000053
Slope8,604,632
Total Sum of Squares28489.3T

Neuronetics Liabilities And Stockholders Equity History

2024100.9 M
2023115.8 M
2022116.9 M
2021141.2 M
202078.7 M
2019100.2 M
2018117 M

About Neuronetics Financial Statements

There are typically three primary documents that fall into the category of financial statements. These documents include Neuronetics income statement, its balance sheet, and the statement of cash flows. Neuronetics investors use historical funamental indicators, such as Neuronetics's Liabilities And Stockholders Equity, to determine how well the company is positioned to perform in the future. Although Neuronetics investors may use each financial statement separately, they are all related. The changes in Neuronetics's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on Neuronetics's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on Neuronetics Financial Statements. Understanding these patterns can help to make the right decision on long term investment in Neuronetics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Liabilities And Stockholders Equity115.8 M100.9 M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Neuronetics using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations
When determining whether Neuronetics is a strong investment it is important to analyze Neuronetics' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Neuronetics' future performance. For an informed investment choice regarding Neuronetics Stock, refer to the following important reports:
Check out the analysis of Neuronetics Correlation against competitors.
To learn how to invest in Neuronetics Stock, please use our How to Invest in Neuronetics guide.
You can also try the USA ETFs module to find actively traded Exchange Traded Funds (ETF) in USA.

Complementary Tools for Neuronetics Stock analysis

When running Neuronetics' price analysis, check to measure Neuronetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Neuronetics is operating at the current time. Most of Neuronetics' value examination focuses on studying past and present price action to predict the probability of Neuronetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Neuronetics' price. Additionally, you may evaluate how the addition of Neuronetics to your portfolios can decrease your overall portfolio volatility.
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Fundamental Analysis
View fundamental data based on most recent published financial statements
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Is Neuronetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Neuronetics. If investors know Neuronetics will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Neuronetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(0.94)
Revenue Per Share
2.523
Quarterly Revenue Growth
0.121
Return On Assets
(0.15)
Return On Equity
(0.72)
The market value of Neuronetics is measured differently than its book value, which is the value of Neuronetics that is recorded on the company's balance sheet. Investors also form their own opinion of Neuronetics' value that differs from its market value or its book value, called intrinsic value, which is Neuronetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Neuronetics' market value can be influenced by many factors that don't directly affect Neuronetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Neuronetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Neuronetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Neuronetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.